Correlation Between Pfizer and KonaTel
Can any of the company-specific risk be diversified away by investing in both Pfizer and KonaTel at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and KonaTel into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pfizer Inc and KonaTel, you can compare the effects of market volatilities on Pfizer and KonaTel and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of KonaTel. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and KonaTel.
Diversification Opportunities for Pfizer and KonaTel
Poor diversification
The 3 months correlation between Pfizer and KonaTel is 0.72. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and KonaTel in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on KonaTel and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with KonaTel. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of KonaTel has no effect on the direction of Pfizer i.e., Pfizer and KonaTel go up and down completely randomly.
Pair Corralation between Pfizer and KonaTel
Considering the 90-day investment horizon Pfizer Inc is expected to generate 0.25 times more return on investment than KonaTel. However, Pfizer Inc is 3.98 times less risky than KonaTel. It trades about -0.05 of its potential returns per unit of risk. KonaTel is currently generating about -0.04 per unit of risk. If you would invest 3,584 in Pfizer Inc on September 1, 2024 and sell it today you would lose (963.00) from holding Pfizer Inc or give up 26.87% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 99.73% |
Values | Daily Returns |
Pfizer Inc vs. KonaTel
Performance |
Timeline |
Pfizer Inc |
KonaTel |
Pfizer and KonaTel Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Pfizer and KonaTel
The main advantage of trading using opposite Pfizer and KonaTel positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, KonaTel can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in KonaTel will offset losses from the drop in KonaTel's long position.Pfizer vs. Crinetics Pharmaceuticals | Pfizer vs. Enanta Pharmaceuticals | Pfizer vs. Amicus Therapeutics | Pfizer vs. Connect Biopharma Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Other Complementary Tools
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |